Privium Fund Management B.V.
13F Reported Value
ⓘ$480.3M
Holdings
60
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Privium Fund Management B.V. disclosed 60 positions worth $480.3M in its Form 13F-HR for Q1 2026, led by $TSLA (Tesla, Inc.) at 17.2% of the equity portfolio, followed by $SHOP and $SPOT. During the quarter the fund opened 7 new positions and exited 4 — including a new stake in $ESPR and a full exit from $MRK. The portfolio is most concentrated in Healthcare (33.9% of disclosed assets). All figures are sourced directly from Privium Fund Management B.V.’s Form 13F-HR filing with the SEC under CIK 1795097.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 50.1#1,478
Quality
$82.5M222,000 sh - —
Quality
$48.3M407,000 sh - —
Quality
$32.5M67,000 sh - 85.8
Quality
$29.3M200,000 sh - 74.6
Quality
$26.0M125,000 sh - 74.4
Quality
$23.0M366,936 sh - 37.1
Quality
$21.8M290,024 sh - 36.8
Quality
$16.0M255,259 sh - 90.2
Quality
$14.1M81,000 sh - 68.0
Quality
$13.8M79,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Tesla, Inc.$TSLA | 50.1#1,478 | $82.5M | 222,000 |
 SHOPIFY INC.$SHOP | — | $48.3M | 407,000 |
 Spotify Technology S.A.$SPOT | — | $32.5M | 67,000 |
 Palantir Technologies Inc.$PLTR | 85.8 | $29.3M | 200,000 |
 AMAZON COM INC$AMZN | 74.6 | $26.0M | 125,000 |
 ARROWHEAD PHARMACEUTICALS, INC.$ARWR | 74.4 | $23.0M | 366,936 |
 IONIS PHARMACEUTICALS INC$IONS | 37.1 | $21.8M | 290,024 |
 Lemonade, Inc.$LMND | 36.8 | $16.0M | 255,259 |
 NVIDIA CORP$NVDA | 90.2 | $14.1M | 81,000 |
 Coinbase Global, Inc.$COIN | 68.0 | $13.8M | 79,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Privium Fund Management B.V.'s 60 positions.
Showing top 10 of 60 holdings.
Sector Allocation
Healthcare
$162.6M
Technology
$104.3M
Industrials
$94.4M
Communication Services
$44.5M
Financials
$41.0M
Consumer Discretionary
$26.0M
Energy
$3.4M
Consumer Staples
$2.8M
Full Holdings — Privium Fund Management B.V. (Q1 2026)
All 60 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $TSLA | Tesla, Inc. | $82.5M | 17.2% | -3% | 50.1 |
| 2 | $SHOP | SHOPIFY INC. | $48.3M | 10.1% | -1% | — |
| 3 | $SPOT | Spotify Technology S.A. | $32.5M | 6.8% | -1% | — |
| 4 | $PLTR | Palantir Technologies Inc. | $29.3M | 6.1% | +0% | 85.8 |
| 5 | $AMZN | AMAZON COM INC | $26.0M | 5.4% | +3% | 74.6 |
| 6 | $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $23.0M | 4.8% | -8% | 74.4 |
| 7 | $IONS | IONIS PHARMACEUTICALS INC | $21.8M | 4.5% | +20% | 37.1 |
| 8 | $LMND | Lemonade, Inc. | $16.0M | 3.3% | +3% | 36.8 |
| 9 | $NVDA | NVIDIA CORP | $14.1M | 2.9% | +0% | 90.2 |
| 10 | $COIN | Coinbase Global, Inc. | $13.8M | 2.9% | +0% | 68 |
| 11 |  $AMD | ADVANCED MICRO DEVICES INC | $12.6M | 2.6% | +3% | 78.8 |
| 12 |  $ASTS | AST SpaceMobile, Inc. | $12.0M | 2.5% | +0% | 29.6 |
| 13 |  $SE | Sea Ltd | $11.4M | 2.4% | +0% | — |
| 14 |  $IREN | IREN Ltd | $11.0M | 2.3% | +14% | — |
| 15 |  $AXSM | Axsome Therapeutics, Inc. | $9.9M | 2.1% | +3% | 36.6 |
| 16 |  $ESPR | Esperion Therapeutics, Inc. | $9.0M | 1.9% | NEW | 34.3 |
| 17 |  $PRQR | ProQR Therapeutics N.V. | $8.9M | 1.8% | +2% | — |
| 18 |  $BIIB | BIOGEN INC. | $8.0M | 1.7% | -40% | 65.6 |
| 19 |  $QURE | uniQure N.V. | $8.0M | 1.7% | +17% | — |
| 20 |  $RARE | Ultragenyx Pharmaceutical Inc. | $7.6M | 1.6% | +2% | 31 |
| 21 |  $ARQT | Arcutis Biotherapeutics, Inc. | $7.6M | 1.6% | +5% | 41.2 |
| 22 |  $BMRN | BIOMARIN PHARMACEUTICAL INC | $5.2M | 1.1% | NEW | 74.1 |
| 23 |  $VRTX | VERTEX PHARMACEUTICALS INC / MA | $5.1M | 1.1% | +21% | 76.6 |
| 24 |  $DNLI | Denali Therapeutics Inc. | $4.9M | 1.0% | NEW | — |
| 25 |  $URGN | UroGen Pharma Ltd. | $4.3M | 0.9% | +11% | — |
| 26 |  $ALNY | ALNYLAM PHARMACEUTICALS, INC. | $4.0M | 0.8% | NEW | 60.9 |
| 27 |  $VRDN | Viridian Therapeutics, Inc.\DE | $3.4M | 0.7% | +0% | 30.5 |
| 28 |  $KRYS | Krystal Biotech, Inc. | $2.9M | 0.6% | -8% | 75.9 |
| 29 |  $ABEV | AMBEV S.A. | $2.8M | 0.6% | -11% | — |
| 30 |  $ZLAB | Zai Lab Ltd | $2.5M | 0.5% | +0% | — |
| 31 |  $BNTX | BioNTech SE | $2.4M | 0.5% | -19% | — |
| 32 |  $ENGN | enGene Therapeutics Inc. | $2.4M | 0.5% | +0% | — |
| 33 |  $CRSP | CRISPR Therapeutics AG | $2.0M | 0.4% | +0% | 4.5 |
| 34 |  $MGTX | MeiraGTx Holdings plc | $1.8M | 0.4% | +6% | — |
| 35 |  $WVE | Wave Life Sciences Ltd. | $1.7M | 0.4% | +25% | — |
| 36 |  $STOK | Stoke Therapeutics, Inc. | $1.6M | 0.3% | -9% | 53.4 |
| 37 |  $FDMT | 4D Molecular Therapeutics, Inc. | $1.6M | 0.3% | -19% | 23.2 |
| 38 |  $BEAM | Beam Therapeutics Inc. | $1.5M | 0.3% | -11% | 12.1 |
| 39 |  $MRNA | Moderna, Inc. | $1.5M | 0.3% | -40% | 15.9 |
| 40 |  $PFE | PFIZER INC | $1.5M | 0.3% | +40% | 69 |
| 41 |  $LXEO | Lexeo Therapeutics, Inc. | $1.2M | 0.2% | +6% | — |
| 42 |  $RNAC | Cartesian Therapeutics, Inc. | $1.1M | 0.2% | +4% | 7.5 |
| 43 |  $MOH | MOLINA HEALTHCARE, INC. | $1.1M | 0.2% | NEW | 60.5 |
| 44 |  $SRPT | Sarepta Therapeutics, Inc. | $1.0M | 0.2% | +7% | 41.6 |
| 45 |  $SLB | SLB LIMITED/NV | $948,197 | 0.2% | -52% | 63.2 |
| 46 |  $RCKT | ROCKET PHARMACEUTICALS, INC. | $866,883 | 0.2% | +42% | — |
| 47 |  $HIMS | Hims & Hers Health, Inc. | $830,400 | 0.2% | +0% | 50.9 |
| 48 |  $TSHA | Taysha Gene Therapies, Inc. | $813,093 | 0.2% | +10% | 4.1 |
| 49 |  $NOV | NOV Inc. | $790,509 | 0.2% | -21% | 50.1 |
| 50 |  $RIG | Transocean Ltd. | $706,785 | 0.1% | -24% | — |
| 51 |  $SA | SEABRIDGE GOLD INC | $703,626 | 0.1% | +5% | — |
| 52 |  $SD | SANDRIDGE ENERGY INC | $632,698 | 0.1% | +0% | 65.5 |
| 53 |  $AUTL | Autolus Therapeutics plc | $501,533 | 0.1% | +11% | — |
| 54 |  $FATE | FATE THERAPEUTICS INC | $497,173 | 0.1% | +12% | 6.7 |
| 55 |  $VYGR | Voyager Therapeutics, Inc. | $463,200 | 0.1% | +26% | 5.5 |
| 56 |  $TDW | TIDEWATER INC | $458,105 | 0.1% | +0% | 64.6 |
| 57 |  $BTG | B2GOLD CORP | $437,041 | 0.1% | NEW | — |
| 58 |  $NE | Noble Corp plc | $336,080 | 0.1% | -37% | — |
| 59 |  $PAAS | PAN AMERICAN SILVER CORP | $213,057 | 0.0% | NEW | — |
| 60 |  $SII | SPROTT INC. | $208,521 | 0.0% | -39% | — |
New Positions (7)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Privium Fund Management B.V. including:
Track Privium Fund Management B.V.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Privium Fund Management B.V. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Privium Fund Management B.V.
13F Pro is an AI hedge fund tracker and stock research platform. For Privium Fund Management B.V. (SEC CIK: 1795097), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Privium Fund Management B.V.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.